Cargando…
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the second most frequent cause of cancer-related mortality worldwide. The multikinase inhibitor sorafenib is the only treatment option for advanced HCC. Due to tumor heterogeneity, its efficacy greatly varies between patients...
Autores principales: | Nuciforo, Sandro, Fofana, Isabel, Matter, Matthias S., Blumer, Tanja, Calabrese, Diego, Boldanova, Tujana, Piscuoglio, Salvatore, Wieland, Stefan, Ringnalda, Femke, Schwank, Gerald, Terracciano, Luigi M., Ng, Charlotte K.Y., Heim, Markus H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088153/ https://www.ncbi.nlm.nih.gov/pubmed/30067989 http://dx.doi.org/10.1016/j.celrep.2018.07.001 |
Ejemplares similares
-
Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors
por: Blumer, Tanja, et al.
Publicado: (2019) -
Gene expression analysis of biopsy samples reveals critical limitations of transcriptome‐based molecular classifications of hepatocellular carcinoma
por: Makowska, Zuzanna, et al.
Publicado: (2016) -
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
por: Meier, Marie-Anne, et al.
Publicado: (2022) -
Organoids to model liver disease
por: Nuciforo, Sandro, et al.
Publicado: (2020) -
Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma
por: Di Blasi, Daniela, et al.
Publicado: (2019)